Evidence map›Paper›PMID 36864491›Full record

ArticleJournal of medical case reports2023

Multiple maxillary periodontal abscesses as a manifestation of post-coronavirus disease 2019 mucormycosis: a case report.

Hossein Khoshkhou, Mahboube Hasheminasab, Daryoush Goudarzi Pour, Raika Jamali, Ghazal Morshedzadeh Tehrani, Neda Moslemi

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of medical case reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.8field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Hossein KhoshkhouDepartment of Periodontology, School of Dentistry, Tehran University of Medical Sciences, Tehran, Iran.
Mahboube HasheminasabDepartment of Orthodontics, Dugoni School of Dentistry, University of the Pacific, San Francisco, USA.
Daryoush Goudarzi PourDepartment of Oral & Maxillofacial Radiology, School of Dentistry, Tehran University of Medical Sciences, Tehran, Iran.
Raika JamaliDigestive Disease Research Institute, Tehran University of Medical Sciences, Tehran, Iran.
Ghazal Morshedzadeh TehraniDepartment of Periodontology, School of Dentistry, Qom University of Medical Sciences, Qom, Iran.
Neda MoslemiDepartment of Periodontology, School of Dentistry, Tehran University of Medical Sciences, Tehran, Iran. neda_moslemi@yahoo.com.
Tehran University of Medical Sciences · IRQom University of Medical Science and Health Services · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCoronavirus disease 2019 makes patients more susceptible to superinfection of fungal disease as a consequence of immunological system impairment. Mucormycosis is a fungal infection that is rare but has a high mortality rate and mostly affects patients with poorly controlled diabetes mellitus or those receiving corticosteroids. CASE PRESENTATION: Here, we present a case of post-coronavirus disease 2019 mucormycosis in a 37-year-old Persian male presenting with multiple periodontal abscess with purulent discharge and necrosis of maxillary bone (without oroantral communication). Surgical debridement following antifungal therapy was the treatment of choice.

conclusionEarly diagnosis and immediate referral are the cornerstone of comprehensive treatment.

Indexed as

MucormycosisPeriodontal AbscessPost-Acute COVID-19 SyndromeAdultAntifungal AgentsDebridementHumansMaleMaxillaNecrosisAntifungal AgentsCOVID-19MucormycosisPeriodontal abscessPost-COVID mucormycosis

Identifiers

PMID36864491
PMCPMC9981442
OpenAlexW4322762321

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.